Australian Pathology Stocks Rise Amid Omicron Worries -- Market Talk
Australian Pathology Stocks Rise Amid Omicron Worries -- Market Talk
0345 GMT - Shares in Australian pathology firms Sonic Healthcare and Healius are higher even as worries over the impact of the Omicron coronavirus variant unsettle the local equities market. Shares in Sonic and Healius, both of which provide lab testing among their services, are up by 2.5% and 3.1% respectively despite the S&P/ASX 200 laboring to recover its early losses. The gains echo those of earlier this year, when Sonic and Healius shares each put on about 30% over three months as Covid-19's Delta variant spread across Australia and lifted demand for testing services. (stuart.condie@wsj.com; @StuartLCondie)
0345GMT-澳大利亞病理公司Sonic Healthcare和Healius的股價上漲，儘管對Omicron冠狀病毒變體影響的擔憂擾亂了當地股市。Sonic和Healius的股價分別上漲了2.5%和3.1%，儘管S&P/ASX 200指數正在努力收復早先的失地。Sonic和Healius的服務都提供實驗室檢測。這一漲幅呼應了今年早些時候的情況，當時隨着新冠肺炎的Delta變體在澳大利亞蔓延，提振了對檢測服務的需求，Sonic和Healius的股價在三個月內分別上漲了約30%。(stuart.Condie@wsj.com；@StuartLCondie)
譯文內容由第三人軟體翻譯。